欧盟HMA药品数据库(European Union HMA Authorisation of Medicines DataBase)
MR编号CZ/V/0159/001
药品名称BelaZin 20 mg/ml solution for injection
活性成分
    • xylazine hydrochloride 20.0 mg
剂型Solution for injection
上市许可持有人Bela-pharm GmbH & Co.KG Lohner Str. 19 49377 Vechta Germany Germany
参考成员国 - 产品名称Czechia (CZ)
BelaZin 20 mg/ml injekční roztok pro skot, koně, psy a kočky
互认成员国 - 产品名称
    • Germany (DE)
    • Netherlands (NL)
    • Luxembourg (LU)
    • Austria (AT)
      BelaZin 20 mg/ml Injektionslösung für Rinder, Pferde, Hunde und Katzen
    • France (FR)
      BELAZIN 20 MG/ML
    • Portugal (PT)
    • Greece (GR)
    • Latvia (LV)
      BelaZin 20 mg/ml šķīdums injekcijām liellopiem, zirgiem, suņiem un kaķiem
    • Lithuania (LT)
      BelaZin 20 mg/ml, injekcinis tirpalas galvijams, arkliams, šunims ir katėms
    • Estonia (EE)
      BelaZin
    • Hungary (HU)
    • Bulgaria (BG)
    • Cyprus (CY)
    • Romania (RO)
    • Slovenia (SI)
    • Croatia (HR)
许可日期2020/02/05
最近更新日期2024/03/15
药物ATC编码
    • QN05CM92 xylazine
申请类型
  • TypeLevel1:food
  • TypeLevel2:Pharmaceutical
  • TypeLevel3:Generic - art 13.2 Dir 2001/82/EC
  • TypeLevel4:[not specified]
  • TypeLevel5:[not specified]
附件文件下载
市场状态Positive
©2006-2025 Drugfuture->European Union HMA Authorisation of Medicines DataBase